- Home
- SRZN vs PRPL Comparison
SRZN vs PRPL Comparison
Compare SRZN & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- PRPL
- Stock Information
- Founded
- SRZN 2015
- PRPL 2010
- Country
- SRZN United States
- PRPL United States
- Employees
- SRZN N/A
- PRPL N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- PRPL Home Furnishings
- Sector
- SRZN Health Care
- PRPL Consumer Discretionary
- Exchange
- SRZN Nasdaq
- PRPL Nasdaq
- Market Cap
- SRZN 120.0M
- PRPL 96.6M
- IPO Year
- SRZN N/A
- PRPL N/A
- Fundamental
- Price
- SRZN $13.06
- PRPL $0.80
- Analyst Decision
- SRZN Strong Buy
- PRPL Hold
- Analyst Count
- SRZN 2
- PRPL 1
- Target Price
- SRZN $38.50
- PRPL $1.00
- AVG Volume (30 Days)
- SRZN 38.1K
- PRPL 423.4K
- Earning Date
- SRZN 11-07-2025
- PRPL 11-04-2025
- Dividend Yield
- SRZN N/A
- PRPL N/A
- EPS Growth
- SRZN N/A
- PRPL N/A
- EPS
- SRZN N/A
- PRPL N/A
- Revenue
- SRZN $12,621,000.00
- PRPL $456,844,000.00
- Revenue This Year
- SRZN N/A
- PRPL N/A
- Revenue Next Year
- SRZN N/A
- PRPL $11.87
- P/E Ratio
- SRZN N/A
- PRPL N/A
- Revenue Growth
- SRZN N/A
- PRPL N/A
- 52 Week Low
- SRZN $5.90
- PRPL $0.56
- 52 Week High
- SRZN $18.17
- PRPL $1.29
- Technical
- Relative Strength Index (RSI)
- SRZN 45.71
- PRPL 35.26
- Support Level
- SRZN $13.42
- PRPL $0.83
- Resistance Level
- SRZN $14.38
- PRPL $0.91
- Average True Range (ATR)
- SRZN 0.42
- PRPL 0.06
- MACD
- SRZN -0.12
- PRPL -0.00
- Stochastic Oscillator
- SRZN 5.63
- PRPL 22.99
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.